Jpmorgan Chase & CO Globus Medical Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Globus Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,604,774 shares of GMED stock, worth $241 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,604,774
Previous 2,635,851
1.18%
Holding current value
$241 Million
Previous $181 Million
3.22%
% of portfolio
0.02%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding GMED
# of Institutions
482Shares Held
104MCall Options Held
183KPut Options Held
57.3K-
Vanguard Group Inc Valley Forge, PA10.6MShares$982 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$956 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07MShares$647 Million0.27% of portfolio
-
State Street Corp Boston, MA3.57MShares$330 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.58MShares$238 Million0.03% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $7.12B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...